FDA Must Recognize Ephedra Ruling’s Nationwide Implications – Emord

A Utah court ruling lifting an FDA ban on low-dose ephedra applies nationwide and cannot be interpreted by the agency as pertaining only to the district where the decision was issued, according to Jonathan Emord of the Washington, D.C. law firm Emord & Associates